Delivery Order SPE2DB20D2014-SPE2DB25FD06G
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $37,709.53. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. Dupixent (dupilumab) is a biologic medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $49,000 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 8, 2025, with completion targeted for September 9, 2025. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a $1,709.46 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Dupixent 300 mg/2 ml syringes (2 ml quantity). This firm fixed-price contract, with a completion date of July 16, 2025, represents a non-set-aside competitive award delivered to the company's Conshohocken, Pennsylvania location. Dupixent is a biologic medication used primarily for treating moderate-to-severe atopic dermatitis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $91,492.20 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions...
- The Defense Logistics Agency awarded a delivery order valued at $5,947.38 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions...
- The Defense Logistics Agency awarded a $13,593.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe...
- The Defense Logistics Agency awarded a delivery order valued at $10,256.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $63,843.95 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL syringes on October 30, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by October 31, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis and other...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,837.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed-price, competitively awarded contract was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent is a prescription biologic medication used to treat various inflammatory conditions, and this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,592.80 for Dupixent 300 mg/2 ml syringes on July 7, 2025, with completion scheduled for July 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic...